BJS:通过磁技术对乳腺癌进行前哨淋巴结活检,效果显著

2016-10-18 MedSci MedSci原创

BJS:通过磁技术对乳腺癌进行前哨淋巴结活检,效果显著双技术(放射性示踪剂和蓝色染料)作为前哨淋巴结活检(SLNB)标准,存在几个缺点。一些临床试验对一种新的、没有这些确定的磁技术进行了评估。它使用一个磁性示踪剂和一个手持式磁力计来识别和切除前哨淋巴结。本项系统回顾和荟萃分析,比较磁技术和标准技术的有效性。检索Medline、PubMed、Embase和Cochrane在线文献数据库,识别截止20

BJS:通过磁技术对乳腺癌进行前哨淋巴结活检,效果显著

双技术(放射性示踪剂和蓝色染料)作为前哨淋巴结活检(SLNB)标准,存在几个缺点。

一些临床试验对一种新的、没有这些确定的磁技术进行了评估。它使用一个磁性示踪剂和一个手持式磁力计来识别和切除前哨淋巴结。

本项系统回顾和荟萃分析,比较磁技术和标准技术的有效性。

检索Medline、PubMed、Embase和Cochrane在线文献数据库,识别截止2016年4月发表的磁技术进行SLNB相关研究。如果研究是前瞻性临床试验,比较了磁技术和标准技术应用于乳腺癌患者的SLNB,将纳入系统回顾和荟萃分析。

共纳入七项研究。磁技术是非劣于标准技术(z = 3.87, P < 0.001)。标准技术和磁技术的平均识别率分别为96.8% (range 94.2–99.0)和97%.1 (94.4–98.0)(风险差(RD)0.00, 95% CI. –0.01 to 0.01; P = 0.690)。磁技术和标准技术相比较,总淋巴结检出显着较高2113 (1.9/人) versus 2000 (1.8 /人) (RD 0.05, 0.03 to 0.06; P = 0.003)。标准技术的假阴性率为10.9%(range 6–22),磁技术的假阴性率为8.4% (2–22)(RD 0.03, 0.00 to 0.06; P = 0.551)。平均差异率为3.9% (range 1.7–6.9)。


前哨淋巴结活检磁技术是非劣于标准技术的,具有高识别率,以及较高的淋巴结检出率。

原始出处:


A. Zada, M. C. L. Peek, M. Ahmed, B. Anninga, R. Baker, M. Kusakabe, M. Sekino, J. M. Klaase, B. ten Haken, M. Douek.Meta‐analysis of sentinel lymph node biopsy in breast cancer using the magnetic technique.BJS.Volume 103 Issue 11 (October 2016)

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1664887, encodeId=ca96166488e68, content=<a href='/topic/show?id=9bd2325e9f7' target=_blank style='color:#2F92EE;'>#前哨淋巴结活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32579, encryptionId=9bd2325e9f7, topicName=前哨淋巴结活检)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=979a25868441, createdName=dlwang_26703135, createdTime=Fri Aug 11 06:33:00 CST 2017, time=2017-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277991, encodeId=22e812e7991b6, content=<a href='/topic/show?id=d34e6523544' target=_blank style='color:#2F92EE;'>#活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65235, encryptionId=d34e6523544, topicName=活检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Thu Oct 20 13:33:00 CST 2016, time=2016-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292974, encodeId=18be12929e4b4, content=<a href='/topic/show?id=df626600877' target=_blank style='color:#2F92EE;'>#淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66008, encryptionId=df626600877, topicName=淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Thu Oct 20 13:33:00 CST 2016, time=2016-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534830, encodeId=5d60153483019, content=<a href='/topic/show?id=47ee325e539' target=_blank style='color:#2F92EE;'>#前哨淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32575, encryptionId=47ee325e539, topicName=前哨淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a89e12549488, createdName=by2013, createdTime=Thu Oct 20 13:33:00 CST 2016, time=2016-10-20, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1664887, encodeId=ca96166488e68, content=<a href='/topic/show?id=9bd2325e9f7' target=_blank style='color:#2F92EE;'>#前哨淋巴结活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32579, encryptionId=9bd2325e9f7, topicName=前哨淋巴结活检)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=979a25868441, createdName=dlwang_26703135, createdTime=Fri Aug 11 06:33:00 CST 2017, time=2017-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277991, encodeId=22e812e7991b6, content=<a href='/topic/show?id=d34e6523544' target=_blank style='color:#2F92EE;'>#活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65235, encryptionId=d34e6523544, topicName=活检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Thu Oct 20 13:33:00 CST 2016, time=2016-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292974, encodeId=18be12929e4b4, content=<a href='/topic/show?id=df626600877' target=_blank style='color:#2F92EE;'>#淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66008, encryptionId=df626600877, topicName=淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Thu Oct 20 13:33:00 CST 2016, time=2016-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534830, encodeId=5d60153483019, content=<a href='/topic/show?id=47ee325e539' target=_blank style='color:#2F92EE;'>#前哨淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32575, encryptionId=47ee325e539, topicName=前哨淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a89e12549488, createdName=by2013, createdTime=Thu Oct 20 13:33:00 CST 2016, time=2016-10-20, status=1, ipAttribution=)]
    2016-10-20 smlt2008
  3. [GetPortalCommentsPageByObjectIdResponse(id=1664887, encodeId=ca96166488e68, content=<a href='/topic/show?id=9bd2325e9f7' target=_blank style='color:#2F92EE;'>#前哨淋巴结活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32579, encryptionId=9bd2325e9f7, topicName=前哨淋巴结活检)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=979a25868441, createdName=dlwang_26703135, createdTime=Fri Aug 11 06:33:00 CST 2017, time=2017-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277991, encodeId=22e812e7991b6, content=<a href='/topic/show?id=d34e6523544' target=_blank style='color:#2F92EE;'>#活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65235, encryptionId=d34e6523544, topicName=活检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Thu Oct 20 13:33:00 CST 2016, time=2016-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292974, encodeId=18be12929e4b4, content=<a href='/topic/show?id=df626600877' target=_blank style='color:#2F92EE;'>#淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66008, encryptionId=df626600877, topicName=淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Thu Oct 20 13:33:00 CST 2016, time=2016-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534830, encodeId=5d60153483019, content=<a href='/topic/show?id=47ee325e539' target=_blank style='color:#2F92EE;'>#前哨淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32575, encryptionId=47ee325e539, topicName=前哨淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a89e12549488, createdName=by2013, createdTime=Thu Oct 20 13:33:00 CST 2016, time=2016-10-20, status=1, ipAttribution=)]
    2016-10-20 sodoo
  4. [GetPortalCommentsPageByObjectIdResponse(id=1664887, encodeId=ca96166488e68, content=<a href='/topic/show?id=9bd2325e9f7' target=_blank style='color:#2F92EE;'>#前哨淋巴结活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32579, encryptionId=9bd2325e9f7, topicName=前哨淋巴结活检)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=979a25868441, createdName=dlwang_26703135, createdTime=Fri Aug 11 06:33:00 CST 2017, time=2017-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277991, encodeId=22e812e7991b6, content=<a href='/topic/show?id=d34e6523544' target=_blank style='color:#2F92EE;'>#活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65235, encryptionId=d34e6523544, topicName=活检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Thu Oct 20 13:33:00 CST 2016, time=2016-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292974, encodeId=18be12929e4b4, content=<a href='/topic/show?id=df626600877' target=_blank style='color:#2F92EE;'>#淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66008, encryptionId=df626600877, topicName=淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Thu Oct 20 13:33:00 CST 2016, time=2016-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534830, encodeId=5d60153483019, content=<a href='/topic/show?id=47ee325e539' target=_blank style='color:#2F92EE;'>#前哨淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32575, encryptionId=47ee325e539, topicName=前哨淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a89e12549488, createdName=by2013, createdTime=Thu Oct 20 13:33:00 CST 2016, time=2016-10-20, status=1, ipAttribution=)]